Fig. 6From: Trends in HPV cervical and seroprevalence and associations between oral and genital infection and serum antibodies in NHANES 2003–2012APC models of cervicogenital HPV prevalence among women, seroprevalence among women, and seroprevalence among men. Age-specific prevalence and relative prevalence by birth cohort (relative to 50 % prevalence) by race for (a, b) cervicogenital prevalence, (c, d) female seroprevalence, and (e, f) male seroprevalenceBack to article page